Home
Company
Products
Pharmacies
Newsroom >
Careers
Contact

 Home  |  Pharmacies  |  Contact 

Newsroom

Company Backgrounder

• Kowa Pharmaceuticals America: A legacy of trust. A future of care.

 

Media Kits

• Livalo Bottles Image
• Livalo Fact Sheet
• Livalo Launch Press Release (PDF)
• Livalo Heart Disease and Cholesterol Fact Sheet (PDF)

Press Releases

2011

•   July 18, 2011- New Data Showed Minimal Potential for Drug Interaction between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy

2010

•   June 21, 2010- Kowa Pharmaceuticals America and Lilly Announce U.S. Availability of Livalo

2009

• December 23, 2009 - Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
• December 14, 2009 - Kowa Pharmacueticals America Announces the Divestment of Cambia and PRO-571
• August 03, 2009 - FDA Approves LIVALO® for Primary Hypercholesterolemia and Combined Dyslipidemia
• June 22, 2009 - FDA Approves Cambia"! for Migraine
• April 14, 2009 - Kowa Pharmaceuticals America Announces Strategic Divestiture of Diclofenac Assets

2008

• August 4, 2008 - Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.